Kratom Leadership Summit Schedule

2020 KRATOM LEADERSHIP SUMMIT

November 11-13, 2020

Tampa Airport Marriott — 4200 George J. Bean Parkway, Tampa, FL 33607

Wednesday, Nov. 11, 2020

https://vimeo.com/472350817

7:30 PM On-site Welcome Reception with light hors d’oeuvres

Registration Open at Hotel

Thursday, Nov. 12, 2020

7:00 AM Registration Open at Hotel

Kratom Summit Kickoff Breakfast

Welcome, Matt Salmon, Chairman of the AKA

Speaker: “Kratom: 2016 to Now” – Utah State Senator Curt Bramble

8:00 AM Speaker: “The Science on Kratom: Needed Research” – Jack Henningfield,

Ph.D., Vice President, Research, Health Policy, and Abuse Liability; Professor,

Adjunct, Behavioral Biology, Department of Psychiatry and Behavioral

Sciences, The Johns Hopkins University School of Medicine.

9:15 AM Break

9:30 AM Panel Discussion: “The Profile of a Kratom Consumer in America” – Oliver

Grundmann, Ph.D., College of Pharmacy, Department of Medicinal Chemistry,

University of Florida; Albert Garcia-Romeu, Ph.D., Department of Psychiatry

and Behavioral Sciences, Johns Hopkins University School of Medicine,

Baltimore, MD; and Kirsten Smith, Ph.D., National Institute on Drug Abuse

Intramural Research Program.

11:00 AM Break

11:15 AM Roundtable Discussion: “Advertising and Social Media Standing of Kratom: The

Metrics” – Mark Allen, AKA

12:00 PM Lunch

Speaker: “A State Legislator’s View of Kratom” – Georgia State Representative

Vernon Jones

1:00 PM Speaker: “Kratom is a Food” – Michael J. Werner, Holland & Knight,

Washington, D.C.

1:45 PM Break

2:00 PM Speaker: “The Potential and Future of Kratom Alkaloids and Their Derivatives

as FDA-Approved Therapies” – Andrew Kruegel, Ph.D., Chief Scientific Officer

and Co-Founder at Kures.

2:45 PM Speaker: “The Kratom Foundation: The Facts on Kratom” – James Morrissette,

CEO and Board Chair.

3:30 PM Break

3:45 PM Panel Discussion: “The Potential for Kratom as a Therapy” – Marc Swogger,

Ph.D., Department of Psychiatry, University of Rochester Medical Center,

Rochester, NY; Paula Brown, Ph.D., Natural Health and Food Products

Research Group, BC Institute of Technology, Burnaby, BC, Canada; Zach

Walsh, Ph.D., Department of Psychology, University of British Columbia,

Kelowna, BC, Canada.

5:00 PM Open Q&A

6:30 PM Kratom Summit Dinner

Keynote Speaker and Recipient of the 2020 AKA Kratom Champion Award:

Congressman Mark Pocan.

Friday, Nov. 13, 2020

7:15 AM Breakfast

8:00 AM Panel Discussion: “The Future of Kratom Exports from Indonesia” – PEKRINDO

Representative; PPHI Representative; and KOMPHAR Representative

9:15 AM Speaker: “CBD and Kratom: Challenges Created by the FDA” — Robert Hoban,

Hoban Law Group, Denver, CO.

10:00 AM Break

10:15 AM Panel Discussion: “NIDA’s Commitment to Kratom Research” — Geoff Laredo,

former NIDA Senior Advisor to the Director of the Office of Science Policy and

Communications; Kirsten Smith, Ph.D., National Institute on Drug Abuse

Intramural Research Program; and Aidan Hampson, Ph.D., Health Science

Administrator, National Institute on Drug Abuse.

11:15 AM Speaker: “Kratom Science: Where We Stand Today” – Chris McCurdy, Ph.D.,

Director and Professor, College of Pharmacy, University of Florida.

12:15 PM Closing Session – “Major Challenges to Keeping Kratom Legal” – Mac Haddow,

Senior Fellow on Public Policy, AKA

1:00 PM SUMMIT ADJOURNED TO 2021

Welcome!

You must be 21+ to purchase Kratom products
You must be 18+ to purchase Botanicals products
You must be 21+ to purchase Amanita Muscaria products

I am I am not

Remember Me
Disclaimer: Kratom: FDA DISCLAIMER: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. KRATOM DISCLAIMER: “This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Wisconsin, Connecticut, Utah; or the following counties: Sarasota County (Florida), San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Rapides (Louisiana)”. Our products are not for use by or sale to persons under the age of 21. WAAVE ALSO RESPECTS COMPLIANCE IN THE FOLLOWING STATES AND COUNTIES: Vermont, Louisiana. Denver CO, Washington D.C., Newport Beach CA, Malheur County, Parker & Monument (CO), Grant Parish (LA), Franklin (NH) and several other counties in Mississippi. We do not ship internationally. ID verification is required for shipments to the following states: Florida, Virginia, West Virginia, Colorado, Oregon, South Dakota, Nebraska, Kentucky, Maryland, Tennessee, Mississippi, Georgia, Rhode Island. Enhanced Kratom cannot be shipped to Tennessee and Georgia. Kratom is NOT used to treat, cure, or mitigate any disease, illness, ailment, and/or condition. Please consult your doctor before consuming any new products. Kratom has not been tested on pregnant women. Please, see the FDA alert 54-15. We make no representations as to intended use or suitability for use. This product contains chemicals known to the state of California to cause cancer, birth defects, or reproductive harm. Specifically nickel, arsenic, and lead. For more information please visit p65warnings.ca.gov. We do not ship to military bases
- Botanicals: We respect federal state and city laws, our shipping restrictions are detailed below on the footer and they are automatically updated by WAAVE compliance FDA Disclaimer: The statements made regarding our products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. We assume no responsibility for the improper use of our products. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice. Merchants may not ship to military bases.

- Amanita Muscaria: This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease. Keep out of reach of children. Not for use by individuals under 21 years of age. Consult a qualified healthcare professional before use. By purchasing this product, you acknowledge that you are responsible for complying with all applicable federal, state, and local laws.
 

WAAVE Compliance